Here, we showed that GRP78 expression was induced in RCC xenografts following anti-angiogenic therapy, and that GRP78 knockdown effectively inhibited tumor proliferation and induced apoptosis in RCC both in vitro and in vivo by impeding UPR pathways. Here, HSPA5 is linked to renal cell carcinoma.